Embedded Files
HCV is a blood borne virus resulting in acute infection and in select individuals, may progress to chronic infection and complications such as cirrhosis and cancer. All patients with chronic HCV should be considered for treatment.
Tools + Resources
Tools + Resources
Tool used to assess severity and prognosis of an individuals liver disease
Interaction checker for hepatitis medications
Canada's Source for HIV and Hepatitis C (CATIE)
Overview of Hepatitis C prevention, diagnostics, treatment and available drugs
American Association For The Study of Liver Diseases
Guidelines for management of treatment naive HCV infection
Student Guide
Student Guide
Hepatitis C.docxTest Your Knowledge
Test Your Knowledge
Your patient scores 8 points on the Child Pugh Scoring tool. How would you classify this patient?
a) Class A compensated cirrhosis
b) Class B compensated cirrhosis
c) Class B decompensated cirrhosis
d) Class C decompensated cirrhosis
Which of the following is NOT a goal of therapy for HCV?
a) Cure hepatitis C
b) Prevent progression to cirrhosis
c) Minimize ADRs
d) Prevent spread of infection
e) None of the above - all are goals of therapy
Sustained virologic response refers to:
a) Completion of treatment for intended duration without experiencing adverse drug events
b) Reduction in Child Pugh score
c) Undetectable viral load 12-24 weeks after treatment
d) Undetectable viral load after treatment completion
Which of the following regimen(s) should be avoided in decompensated cirrhosis?
a) SOF/VEL
b) GLE/PIB
c) SOF/VEL/VOX
d) B and C
Your patient with genotype 1 compensated cirrhosis will be using GLE/PIB for treatment of HCV. They are treatment naive. What is the recommended duration of therapy?
a) 8 weeks
b) 12 weeks
c) 16 weeks
d) GLE/PIB is not indicated for treatment naive patients
Answer Key
Answer Key
c
e
c
d
a
Page updated
Google Sites
Report abuse